Debt to Equity
since 2012
Calculation
Zoetis Inc., debt to equity, long-term trends, calculation
| Debt to equity | = | Short-term borrowings and long-term debt1 | ÷ | Total Zoetis Inc. equity1 | |
|---|---|---|---|---|---|
| Dec 31, 2019 | 2.38 | = | 6,447 | ÷ | 2,708 |
| Dec 31, 2018 | 2.95 | = | 6,452 | ÷ | 2,185 |
| Dec 31, 2017 | 2.80 | = | 4,953 | ÷ | 1,770 |
| Dec 31, 2016 | 3.00 | = | 4,468 | ÷ | 1,487 |
| Dec 31, 2015 | 4.56 | = | 4,868 | ÷ | 1,068 |
| Dec 31, 2014 | 2.78 | = | 3,650 | ÷ | 1,311 |
| Dec 31, 2013 | 3.89 | = | 3,657 | ÷ | 940 |
| Dec 31, 2012 | 0.14 | = | 582 | ÷ | 4,026 |
Based on: 10-K (filing date: 2020-02-13), 10-K (filing date: 2019-02-14), 10-K (filing date: 2018-02-15), 10-K (filing date: 2017-02-16), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-27), 10-K (filing date: 2014-03-26), 10-K (filing date: 2013-03-28).
1 US$ in millions
Comparison to Competitors
Zoetis Inc., debt to equity, long-term trends, comparison to competitors
| Zoetis Inc. | Abbott Laboratories | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Eli Lilly & Co. | Gilead Sciences Inc. | Illumina Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2019 | 2.38 | 0.58 | — | 3.09 | 0.91 | 5.88 | 1.09 | 0.25 | 0.47 | 1.02 | 0.83 | 0.06 | 0.09 |
| Dec 31, 2018 | 2.95 | 0.64 | — | 2.71 | 0.52 | 1.30 | 1.28 | 0.53 | 0.51 | 0.94 | 0.66 | 0.08 | 0.13 |
| Dec 31, 2017 | 2.80 | 0.90 | 7.33 | 1.40 | 0.68 | 1.18 | 1.64 | 0.49 | 0.57 | 0.71 | 0.60 | 0.11 | 0.29 |
| Dec 31, 2016 | 3.00 | 1.07 | 7.95 | 1.16 | 0.41 | 0.74 | 1.39 | 0.58 | 0.39 | 0.62 | 0.71 | 0.11 | 0.71 |
| Dec 31, 2015 | 4.56 | 0.42 | 8.03 | 1.12 | 0.47 | 0.55 | 1.20 | 0.60 | 0.28 | 0.59 | 0.60 | 0.10 | 0.86 |
| Dec 31, 2014 | 2.78 | 0.36 | 8.62 | 1.19 | 0.53 | 0.52 | 0.80 | 0.88 | 0.27 | 0.44 | 0.51 | 0.18 | 0.75 |
| Dec 31, 2013 | 3.89 | 0.26 | 3.28 | 1.45 | 0.55 | 0.30 | 0.58 | 0.57 | 0.25 | 0.50 | 0.48 | 0.26 | 0.36 |
| Dec 31, 2012 | 0.14 | 0.77 | 4.66 | 1.39 | 0.54 | 0.37 | 0.88 | 0.64 | 0.25 | 0.39 | 0.46 | 0.37 | 0.68 |
Based on: 10-K (filing date: 2020-02-13), 10-K (filing date: 2019-02-14), 10-K (filing date: 2018-02-15), 10-K (filing date: 2017-02-16), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-27), 10-K (filing date: 2014-03-26), 10-K (filing date: 2013-03-28).
Comparison to Sector (Pharmaceuticals & Biotechnology)
Zoetis Inc., debt to equity, long-term trends, comparison to sector (pharmaceuticals & biotechnology)
| Zoetis Inc. | Pharmaceuticals & Biotechnology | |
|---|---|---|
| Dec 31, 2019 | 2.38 | 1.12 |
| Dec 31, 2018 | 2.95 | 1.00 |
| Dec 31, 2017 | 2.80 | 0.93 |
| Dec 31, 2016 | 3.00 | 0.84 |
| Dec 31, 2015 | 4.56 | 0.70 |
| Dec 31, 2014 | 2.78 | 0.57 |
| Dec 31, 2013 | 3.89 | 0.53 |
| Dec 31, 2012 | 0.14 | 0.55 |
Based on: 10-K (filing date: 2020-02-13), 10-K (filing date: 2019-02-14), 10-K (filing date: 2018-02-15), 10-K (filing date: 2017-02-16), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-27), 10-K (filing date: 2014-03-26), 10-K (filing date: 2013-03-28).
Comparison to Industry (Health Care)
Zoetis Inc., debt to equity, long-term trends, comparison to industry (health care)
| Zoetis Inc. | Health Care | |
|---|---|---|
| Dec 31, 2019 | 2.38 | 0.91 |
| Dec 31, 2018 | 2.95 | 0.83 |
| Dec 31, 2017 | 2.80 | 0.84 |
| Dec 31, 2016 | 3.00 | 0.79 |
| Dec 31, 2015 | 4.56 | 0.71 |
| Dec 31, 2014 | 2.78 | 0.55 |
| Dec 31, 2013 | 3.89 | 0.51 |
| Dec 31, 2012 | 0.14 | 0.53 |
Based on: 10-K (filing date: 2020-02-13), 10-K (filing date: 2019-02-14), 10-K (filing date: 2018-02-15), 10-K (filing date: 2017-02-16), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-27), 10-K (filing date: 2014-03-26), 10-K (filing date: 2013-03-28).